Thomas Büchner

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

Susanne Schnittger, Claudia Schoch, Martin Dugas et al. · Blood · 2002 · 962 citations · Full text

Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia

Teresa Padró, Sandra Ruíz, Ralf Bieker et al. · Blood · 2000 · 470 citations

An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia

Klaus H. Metzeler, Manuela Hummel, Clara D. Bloomfield et al. · Blood · 2008 · 445 citations · Full text

Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group

Thomas Büchner, Wolfgang E. Berdel, Claudia Haferlach et al. · Journal of Clinical Oncology · 2008 · 337 citations

Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group.

Thomas Büchner, Wolfgang Hiddemann, Bernhard Wörmann et al. · PubMed · 1999 · 321 citations